[[image:Main complications of persistent high blood pressure.svg|thumb|right|250px|Main complications of persistent [[high blood pressure]]]]
'''Complications of hypertension''' are clinical outcomes that result from [[hypertension|persistent elevation]] of [[blood pressure]].<ref name="pmid19393824">{{cite journal |author=White WB |title=Defining the problem of treating the patient with hypertension and arthritis pain |journal=[[The American Journal of Medicine]] |volume=122 |issue=5 Suppl |pages=S3–9 |year=2009 |month=May |pmid=19393824 |doi=10.1016/j.amjmed.2009.03.002 |url=http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(09)00206-X|accessdate=2009-06-22}}</ref> Hypertension is a risk factor for all clinical manifestations of [[atherosclerosis]] since it is a risk factor for atherosclerosis itself.<ref name="pmid19110086">{{cite journal |author=Insull W |title=The pathology of atherosclerosis: plaque development and plaque responses to medical treatment |journal=[[The American Journal of Medicine]] |volume=122 |issue=1 Suppl |pages=S3–S14 |year=2009 |month=January |pmid=19110086 |doi=10.1016/j.amjmed.2008.10.013 |url=http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(08)01017-6|accessdate=2009-06-20}}</ref><ref name="pmid19394559">{{cite journal |author=Liapis CD, Avgerinos ED, Kadoglou NP, Kakisis JD |title=What a vascular surgeon should know and do about atherosclerotic risk factors |journal=[[Journal of Vascular Surgery]] |volume=49 |issue=5 |pages=1348–54 |year=2009 |month=May |pmid=19394559 |doi=10.1016/j.jvs.2008.12.046 |url=http://linkinghub.elsevier.com/retrieve/pii/S0741-5214(08)02276-3|accessdate=2009-06-20}}</ref><ref name="pmid19275607">{{cite journal |author=Riccioni G |title=The effect of antihypertensive drugs on carotid intima media thickness: an up-to-date review |journal=[[Current Medicinal Chemistry]] |volume=16 |issue=8 |pages=988–96 |year=2009 |pmid=19275607 |doi= 10.2174/092986709787581923|url=http://www.bentham-direct.org/pages/content.php?CMC/2009/00000016/00000008/0006C.SGM|accessdate=2009-06-20}}</ref><ref name="pmid19138169">{{cite journal |author=Safar ME, Jankowski P |title=Central blood pressure and hypertension: role in cardiovascular risk assessment |journal=[[Clinical Science]] |volume=116 |issue=4 |pages=273–82 |year=2009 |month=February |pmid=19138169 |doi=10.1042/CS20080072 |url=http://www.clinsci.org/cs/116/0273/cs1160273.htm|accessdate=2009-06-20}}</ref><ref name="pmid19124420">{{cite journal |author=Werner CM, Böhm M |title=The therapeutic role of RAS blockade in chronic heart failure |journal=[[Therapeutic Advances in Cardiovascular Disease]] |volume=2 |issue=3 |pages=167–77 |year=2008 |month=June |pmid=19124420 |doi=10.1177/1753944708091777 |url=http://tak.sagepub.com/cgi/pmidlookup?view=long&pmid=19124420|accessdate=2009-06-20}}</ref> It is an independent predisposing factor for [[heart failure]],<ref name="pmid19427498">{{cite journal |author=Gaddam KK, Verma A, Thompson M, Amin R, Ventura H |title=Hypertension and cardiac failure in its various forms |journal=[[The Medical Clinics of North America]] |volume=93 |issue=3 |pages=665–80 |year=2009 |month=May |pmid=19427498 |doi=10.1016/j.mcna.2009.02.005 |url=http://journals.elsevierhealth.com/retrieve/pii/S0025-7125(09)00020-0|accessdate=2009-06-20}}</ref><ref name="pmid19427502">{{cite journal |author=Reisin E, Jack AV |title=Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches |journal=[[The Medical Clinics of North America]] |volume=93 |issue=3 |pages=733–51 |year=2009 |month=May |pmid=19427502 |doi=10.1016/j.mcna.2009.02.010 |url=http://journals.elsevierhealth.com/retrieve/pii/S0025-7125(09)00025-X|accessdate=2009-06-20}}</ref> [[coronary artery disease]],<ref name="pmid18815511">{{cite journal |author=Agabiti-Rosei E |title=From macro- to microcirculation: benefits in hypertension and diabetes |journal=[[Journal of Hypertension]] |volume=26 Suppl 3 |issue= |pages=S15–21 |year=2008 |month=September |pmid=18815511 |doi=10.1097/01.hjh.0000334602.71005.52 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0263-6352&volume=26&issue=&spage=S15|accessdate=2009-06-20}}</ref><ref name="pmid19363848">{{cite journal |author=Agabiti-Rosei E |title=From macro- to microcirculation: benefits in hypertension and diabetes |journal=[[Journal of Hypertension Supplement]] |volume=26 |issue=3 |pages=S15–9 |year=2008 |month=September |pmid=19363848 |doi= |url= }}</ref><ref name="pmid19427499">{{cite journal |author=Murphy BP, Stanton T, Dunn FG |title=Hypertension and myocardial ischemia |journal=[[The Medical Clinics of North America]] |volume=93 |issue=3 |pages=681–95 |year=2009 |month=May |pmid=19427499 |doi=10.1016/j.mcna.2009.02.003 |url=http://journals.elsevierhealth.com/retrieve/pii/S0025-7125(09)00018-2|accessdate=2009-06-20}}</ref> [[stroke]],<ref name="pmid19393824">{{cite journal |author=White WB |title=Defining the problem of treating the patient with hypertension and arthritis pain |journal=[[The American Journal of Medicine]] |volume=122 |issue=5 Suppl |pages=S3–9 |year=2009 |month=May |pmid=19393824 |doi=10.1016/j.amjmed.2009.03.002 |url=http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(09)00206-X|accessdate=2009-06-20}}</ref> [[renal disease]],<ref name="pmid12728683">{{cite journal |author=Tylicki L, Rutkowski B |title=[Hypertensive nephropathy: pathogenesis, diagnosis and treatment] |language=Polish |journal=[[Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego]] |volume=14 |issue=80 |pages=168–73 |year=2003 |month=February |pmid=12728683 |doi= |url= }}</ref><ref name="pmid19195963">{{cite journal |author=Truong LD, Shen SS, Park MH, Krishnan B |title=Diagnosing nonneoplastic lesions in nephrectomy specimens |journal=[[Archives of Pathology & Laboratory Medicine]] |volume=133 |issue=2 |pages=189–200 |year=2009 |month=February |pmid=19195963 |doi= 10.1043/1543-2165-133.2.189|url=http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=133&page=189|accessdate=2009-06-20}}</ref><ref name="pmid11842376">{{cite journal |author=Tracy RE, White S |title=A method for quantifying adrenocortical nodular hyperplasia at autopsy: some use of the method in illuminating hypertension and atherosclerosis |journal=[[Annals of Diagnostic Pathology]] |volume=6 |issue=1 |pages=20–9 |year=2002 |month=February |pmid=11842376 |doi= 10.1053/adpa.2002.30606|url=http://linkinghub.elsevier.com/retrieve/pii/S1092913402249217|accessdate=2009-06-20}}</ref> and [[peripheral arterial disease]].<ref name="pmid18672184">{{cite journal |author=Aronow WS |title=Hypertension and the older diabetic |journal=[[Clinics in Geriatric Medicine]] |volume=24 |issue=3 |pages=489–501, vi–vii |year=2008 |month=August |pmid=18672184 |doi=10.1016/j.cger.2008.03.001 |url=http://journals.elsevierhealth.com/retrieve/pii/S0749-0690(08)00012-8|accessdate=2009-06-20}}</ref><ref name="pmid19008688">{{cite journal |author=Gardner AW, Afaq A |title=MANAGEMENT OF LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE |journal=[[Journal of Cardiopulmonary Rehabilitation and Prevention]] |volume=28 |issue=6 |pages=349–57 |year=2008 |pmid=19008688 |doi=10.1097/HCR.0b013e31818c3b96 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1932-7501&volume=28&issue=6&spage=349|accessdate=2009-06-20 |pmc=2743684}}</ref> It is the most important [[risk factor]] for [[cardiovascular]] [[morbidity]] and [[mortality rate|mortality]], in [[industrialized countries]].<ref name="pmid19149532">{{cite journal |author=Novo S, Lunetta M, Evola S, Novo G |title=Role of ARBs in the blood hypertension therapy and prevention of cardiovascular events |journal=[[Current Drug Targets]] |volume=10 |issue=1 |pages=20–5 |year=2009 |month=January |pmid=19149532 |doi= 10.2174/138945009787122897|url=http://www.bentham-direct.org/pages/content.php?CDT/2009/00000010/00000001/0003J.SGM|accessdate=2009-06-20}}</ref>

== Complications affecting the heart ==
{{main|Left ventricular hypertrophy|Hypertensive cardiomyopathy|Myocardial infarction}}
[[Image:Heart left ventricular hypertrophy sa.jpg|thumb|right|290px|[[Left ventricular hypertrophy]]]]
[[Hypertensive heart disease]] is the result of structural and functional adaptations<ref name="pmid19343394">{{cite journal |author=Steinmetz M, Nickenig G |title=[Cardiac sequelae of hypertension] |language=German |journal=[[Der Internist]] |volume=50 |issue=4 |pages=397–409 |year=2009 |month=April |pmid=19343394 |doi=10.1007/s00108-008-2289-3}}</ref> leading to [[left ventricular hypertrophy]],<ref name="pmid16802514">{{cite journal |author=Hennersdorf MG, Strauer BE |title=[Hypertension and heart] |language=German |journal=[[Medizinische Klinik]] |volume=101 Suppl 1 |issue= |pages=27–30 |year=2006 |month=March |pmid=16802514 |doi= |url= }}</ref><ref name="pmid17260148">{{cite journal |author=Hennersdorf MG, Strauer BE |title=[The heart in hypertension] |language=German |journal=[[Der Internist]] |volume=48 |issue=3 |pages=236–45 |year=2007 |month=March |pmid=17260148 |doi=10.1007/s00108-006-1762-0}}</ref><ref name="pmid15351931">{{cite journal |author=Motz W |title=[Right ventricle in arterial hypertension] |language=German |journal=[[Der Internist]] |volume=45 |issue=10 |pages=1108–16 |year=2004 |month=October |pmid=15351931 |doi=10.1007/s00108-004-1273-9}}</ref> [[diastolic dysfunction]],<ref name="pmid19343394"/><ref name="pmid17260148"/> [[Heart failure|CHF]], abnormalities of [[blood flow]] due to [[atherosclerosis|atherosclerotic]] [[coronary artery disease]]<ref name="pmid19343394"/> and [[microvascular disease]],<ref name="pmid18815511">{{cite journal |author=Agabiti-Rosei E |title=From macro- to microcirculation: benefits in hypertension and diabetes |journal=[[Journal of Hypertension]] |volume=26 Suppl 3 |issue= |pages=S15–21 |year=2008 |month=September |pmid=18815511 |doi=10.1097/01.hjh.0000334602.71005.52 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0263-6352&volume=26&issue=&spage=S15|accessdate=2009-06-22}}</ref><ref name="pmid19363848">{{cite journal |author=Agabiti-Rosei E |title=From macro- to microcirculation: benefits in hypertension and diabetes |journal=[[Journal of Hypertension Supplement]] |volume=26 |issue=3 |pages=S15–9 |year=2008 |month=September |pmid=19363848 |doi= |url= }}</ref><ref name="pmid16802514"/> and [[cardiac arrhythmias]].<ref name="pmid16802514"/> Individuals with left ventricular hypertrophy are at increased risk for, [[stroke]],<ref name="pmid19124445">{{cite journal |author=Wachtell K, Devereux RB, Lyle PA, Okin PM, Gerdts E |title=The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy |journal=[[Therapeutic Advances in Cardiovascular Disease]] |volume=2 |issue=6 |pages=507–13 |year=2008 |month=December |pmid=19124445 |doi=10.1177/1753944708093846 |url=http://tak.sagepub.com/cgi/pmidlookup?view=long&pmid=19124445|accessdate=2009-06-22}}</ref> [[Heart failure|CHF]],<ref name="pmid19124445"/> and [[Sudden cardiac death|sudden death]].<ref name="pmid19124445"/> Aggressive control of hypertension can regress or reverse left ventricular hypertrophy and reduce the risk of [[cardiovascular disease]].<ref name="pmid19097374">{{cite journal |author=Petrović D, Stojimirović B |title=[Left ventricular hypertrophy in patients treated with regular hemodialyses] |language=Serbian |journal=[[Medicinski Pregled]] |volume=61 |issue=7–8 |pages=369–74 |year=2008 |pmid=19097374 |doi= 10.2298/MPNS0808369P|url= }}</ref>
<ref name="pmid18367014">{{cite journal |author=Cuspidi C, Sala C, Zanchetti A |title=Management of hypertension in patients with left ventricular hypertrophy |journal=[[Current Hypertension Reports]] |volume=9 |issue=6 |pages=498–505 |year=2007 |month=December |pmid=18367014 |doi= 10.1007/s11906-007-0091-6|url= }}</ref><ref name="pmid17696957">{{cite journal |author=Simko F |title=Statins: a perspective for left ventricular hypertrophy treatment |journal=[[European Journal of Clinical Investigation]] |volume=37 |issue=9 |pages=681–91 |year=2007 |month=September |pmid=17696957 |doi=10.1111/j.1365-2362.2007.01837.x |url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0014-2972&date=2007&volume=37&issue=9&spage=681|accessdate=2009-06-22}}</ref><ref name="pmid17686377">{{cite journal |author=Wachtell K, Devereux RB, Lyle AP |title=The effect of angiotensin receptor blockers for preventing atrial fibrillation |journal=[[Current Hypertension Reports]] |volume=9 |issue=4 |pages=278–83 |year=2007 |month=August |pmid=17686377 |doi= 10.1007/s11906-007-0051-1|url= }}</ref> left ventricular hypertrophy are seen in 25% of the hypertensive patients and can easily be diagnosed by using [[echocardiography]].<ref name="pmid10358398">{{cite journal |author=Herpin D |title=[Impact of arterial hypertension on the heart] |language=French |journal=[[La Revue du praticien]] |volume=49 |issue=5 |pages=491–4 |year=1999 |month=March |pmid=10358398 |doi= |url= }}</ref> Underlying mechanisms of hypertensive left ventricular hypertrophy are of 2 types: [[Mechanics|mechanical]], mainly leading to [[myocyte]] [[hypertrophy]]; [[neuro-hormonal]], mainly resulting in a [[fibroblast]]ic [[cell growth|proliferation]].<ref name="pmid10358398"/>

Abnormalities of diastolic function, ranging from asymptomatic [[heart disease]]<ref name="pmid19532102">{{cite journal |author=Parekh N, Maisel AS |title=Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure |journal=[[Current Opinion in Cardiology]] |volume=24 |issue=2 |pages=155–60 |year=2009 |month=March |pmid=19532102 |doi=10.1097/HCO.0b013e328320d82a |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0268-4705&volume=24&issue=2&spage=155|accessdate=2009-06-22}}</ref><ref name="pmid18828641">{{cite journal |author=Biria M, Howard PA, Vacek J |title=Do statins have a role in the management of diastolic dysfunction? |journal=[[American Journal of Cardiovascular Drugs]] |volume=8 |issue=5 |pages=297–303 |year=2008 |pmid=18828641 |doi= 10.2165/00129784-200808050-00002|url= }}</ref><ref name="pmid17650687">{{cite journal |author=Caserta MA, Milan A, Naso D, ''et al.'' |title=[Left ventricular diastolic function and dysfunction: a single cardiac target for various systemic diseases] |language=Italian |journal=[[Giornale Italiano Di Cardiologia]] |volume=8 |issue=5 |pages=279–98 |year=2007 |month=May |pmid=17650687 |doi= |url= }}</ref> to overt [[heart failure]],<ref name="pmid19427497">{{cite journal |author=Verma A, Solomon SD |title=Diastolic dysfunction as a link between hypertension and heart failure |journal=[[The Medical Clinics of North America]] |volume=93 |issue=3 |pages=647–64 |year=2009 |month=May |pmid=19427497 |doi=10.1016/j.mcna.2009.02.013 |url=http://journals.elsevierhealth.com/retrieve/pii/S0025-7125(09)00029-7|accessdate=2009-06-22}}</ref><ref name="pmid17575480">{{cite journal |author=Ellis CR, Di Salvo T |title=Myocarditis: basic and clinical aspects |journal=[[Cardiology in Review]] |volume=15 |issue=4 |pages=170–7 |year=2007 |pmid=17575480 |doi=10.1097/CRD.0b013e31806450c4 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1061-5377&volume=15&issue=4&spage=170|accessdate=2009-06-22}}</ref> are common in hypertensive patients. Patients with diastolic heart failure have a preserved [[ejection fraction]], which is a measure of systolic function.<ref name="pmid17505622">{{cite journal |author=Okoshi K, Guimarães JF, Di Muzio BP, Fernandes AA, Okoshi MP |title=[Diabetic cardiomyopathy] |language=Portuguese |journal=[[Arquivos Brasileiros De Endocrinologia E Metabologia]] |volume=51 |issue=2 |pages=160–7 |year=2007 |month=March |pmid=17505622 |doi= |url=http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302007000200004&lng=en&nrm=iso&tlng=en|accessdate=2009-06-22}}</ref><ref name="pmid17470335">{{cite journal |author=Fukuta H, Little WC |title=Diagnosis of diastolic heart failure |journal=[[Current Cardiology Reports]] |volume=9 |issue=3 |pages=224–8 |year=2007 |month=May |pmid=17470335 |doi= 10.1007/BF02938354|url= }}</ref> Diastolic dysfunction is an early consequence of hypertension-related heart disease and is exacerbated by left ventricular hypertrophy<ref name="pmid17260148"/><ref name="pmid17470335"/> and [[ischemia]].

== Complications affecting the brain ==
{{Main|Hypertensive encephalopathy|Cerebrovascular accident}}
Hypertension is an important risk factor for [[Infarction|brain infarction]] and hemorrhage.<ref name="pmid19393824"/><ref name="pmid19363848"/><ref name="pmid19308341">{{cite journal |author=Schrader J |title=[Stroke and hypertension] |language=German |journal=[[Der Internist]] |volume=50 |issue=4 |pages=423–32 |year=2009 |month=April |pmid=19308341 |doi=10.1007/s00108-008-2291-9}}</ref><ref name="pmid19330604">{{cite journal |author=Zeng C, Villar VA, Yu P, Zhou L, Jose PA |title=Reactive oxygen species and dopamine receptor function in essential hypertension |journal=[[Clinical and Experimental Hypertension]] |volume=31 |issue=2 |pages=156–78 |year=2009 |month=April |pmid=19330604 |doi=10.1080/10641960802621283 |url=http://www.informaworld.com/openurl?genre=article&doi=10.1080/10641960802621283&magic=pubmed&#124;&#124;1B69BA326FFE69C3F0A8F227DF8201D0|accessdate=2009-06-20}}</ref><ref name="pmid17920983">{{cite journal |author=Varon J |title=Diagnosis and management of labile blood pressure during acute cerebrovascular accidents and other hypertensive crises |journal=[[The American Journal of Emergency Medicine]] |volume=25 |issue=8 |pages=949–59 |year=2007 |month=October |pmid=17920983 |doi=10.1016/j.ajem.2007.02.032 |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-6757(07)00174-X|accessdate=2009-06-20}}</ref><ref name="pmid19342846">{{cite journal |author=Sare GM, Geeganage C, Bath PM |title=High blood pressure in acute ischaemic stroke--broadening therapeutic horizons |journal=[[Cerebrovascular Diseases]] |volume=27 Suppl 1 |issue= |pages=156–61 |year=2009 |pmid=19342846 |doi=10.1159/000200454 |url=http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000200454|accessdate=2009-06-20}}</ref><ref name="pmid19355997">{{cite journal |author=Palm F, Urbanek C, Grau A |title=Infection, its treatment and the risk for stroke |journal=[[Current Vascular Pharmacology]] |volume=7 |issue=2 |pages=146–52 |year=2009 |month=April |pmid=19355997 |doi= 10.2174/157016109787455707|url=http://www.bentham-direct.org/pages/content.php?CVP/2009/00000007/00000002/004AD.SGM|accessdate=2009-06-20}}</ref><ref name="pmid19348237">{{cite journal |author=Tanahashi N |title=[Roles of angiotensin II receptor blockers in stroke prevention] |language=Japanese |journal=[[Nippon Rinsho]] |volume=67 |issue=4 |pages=742–9 |year=2009 |month=April |pmid=19348237 |doi= |url= }}</ref> Approximately 85% of strokes are due to [[infarction]] and the remainder are due to [[hemorrhage]], either [[intracerebral hemorrhage]] or [[subarachnoid hemorrhage]].<ref name="isbn0-07-147691-1">{{cite book |author=Loscalzo, Joseph; Fauci, Anthony S.; Braunwald, Eugene; Dennis L. Kasper; Hauser, Stephen L; Longo, Dan L. |authorlink= |editor= |others= |title=Harrison's principles of internal medicine |edition= |language= |publisher=McGraw-Hill Medical |location= |year=2008 |origyear= |pages= |quote= |isbn=0-07-147691-1 |oclc= |doi= |url= |accessdate=}}</ref> The [[Incidence (epidemiology)|incidence]] of stroke rises progressively with increasing blood pressure levels, particularly [[systolic blood pressure]] in individuals >65 years. [[Treatment of hypertension]] convincingly decreases the incidence of both ischemic and hemorrhagic [[strokes]].<ref name="isbn0-07-147691-1"/>

Hypertension is also associated with [[impaired cognition]] in an [[Population ageing|aging population]],<ref name="pmid19064785">{{cite journal |author=Iadecola C, Park L, Capone C |title=Threats to the Mind: Aging, Amyloid, and Hypertension |journal=[[Stroke (journal)|Stroke]] |volume=40 |issue=3 Suppl |pages=S40–4 |year=2009 |month=March |pmid=19064785 |doi=10.1161/STROKEAHA.108.533638 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=19064785|accessdate=2009-06-22 |pmc=2704500}}</ref><ref name="pmid19182465">{{cite journal |author=Erkinjuntti T, Gauthier S |title=The concept of vascular cognitive impairment |journal=[[Frontiers of Neurology and Neuroscience]] |volume=24 |issue= |pages=79–85 |year=2009 |pmid=19182465 |doi=10.1159/000197886 |url=http://content.karger.com/produktedb/produkte.asp?doi=10.1159/000197886&typ=pdf|accessdate=2009-06-22 |series=Frontiers of Neurology and Neuroscience |isbn=978-3-8055-9015-0}}</ref><ref name="pmid19182465">{{cite journal |author=Erkinjuntti T, Gauthier S |title=The concept of vascular cognitive impairment |journal=[[Frontiers of Neurology and Neuroscience]] |volume=24 |issue= |pages=79–85 |year=2009 |pmid=19182465 |doi=10.1159/000197886 |url=http://content.karger.com/produktedb/produkte.asp?doi=10.1159/000197886&typ=pdf|accessdate=2009-06-23 |series=Frontiers of Neurology and Neuroscience |isbn=978-3-8055-9015-0}}</ref><ref name="pmid18650838">{{cite journal |author=Birns J, Kalra L |title=Cognitive function and hypertension |journal=[[Journal of Human Hypertension]] |volume=23 |issue=2 |pages=86–96 |year=2009 |month=February |pmid=18650838 |doi=10.1038/jhh.2008.80}}</ref><ref name="pmid18561514">{{cite journal |author=Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G |title=Risk factors for vascular dementia: Hypotension as a key point |journal=[[Vascular Health and Risk Management]] |volume=4 |issue=2 |pages=395–402 |year=2008 |pmid=18561514 |pmc=2496988 |doi= |url= }}</ref> Hypertension-related cognitive impairment and dementia may be a consequence of a single infarct due to occlusion of a "strategic" larger vessel<ref name="pmid19011505">{{cite journal |author=Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M |title=Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature |journal=[[Medicine (journal)|Medicine]] |volume=87 |issue=6 |pages=335–44 |year=2008 |month=November |pmid=19011505 |doi=10.1097/MD.0b013e3181908e96 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0025-7974&volume=87&issue=6&spage=335|accessdate=2009-06-23}}</ref> or multiple lacunar infarcts due to occlusive small vessel disease resulting in subcortical [[white matter]] ischemia.<ref name="pmid19182465"/><ref name="pmid18561514">{{cite journal |author=Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G |title=Risk factors for vascular dementia: Hypotension as a key point |journal=[[Vascular Health and Risk Management]] |volume=4 |issue=2 |pages=395–402 |year=2008 |pmid=18561514 |pmc=2496988 |doi= |url= }}</ref><ref name="pmid19342851">{{cite journal |author=Pantoni L, Poggesi A, Inzitari D |title=Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts |journal=[[Cerebrovascular Diseases]] |volume=27 Suppl 1 |issue= |pages=191–6 |year=2009 |pmid=19342851 |doi=10.1159/000200459 |url=http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000200459|accessdate=2009-06-23}}</ref><ref name="pmid19342851"/><ref name="pmid19342851"/> Several [[clinical trial]]s suggest that antihypertensive therapy has a beneficial effect on [[Cognition|cognitive function]], although this remains an active area of investigation.<ref name="pmid19182467">{{cite journal |author=Zekry D |title=Is it possible to treat vascular dementia? |journal=[[Frontiers of Neurology and Neuroscience]] |volume=24 |issue= |pages=95–106 |year=2009 |pmid=19182467 |doi=10.1159/000197888 |url=http://content.karger.com/produktedb/produkte.asp?doi=10.1159/000197888&typ=pdf|accessdate=2009-06-23 |series=Frontiers of Neurology and Neuroscience |isbn=978-3-8055-9015-0}}</ref><ref name="pmid19171835">{{cite journal |author=Viswanathan A, Rocca WA, Tzourio C |title=Vascular risk factors and dementia: How to move forward? |journal=[[Neurology (journal)|Neurology]] |volume=72 |issue=4 |pages=368–74 |year=2009 |month=January |pmid=19171835 |doi=10.1212/01.wnl.0000341271.90478.8e |url=http://www.neurology.org/cgi/pmidlookup?view=long&pmid=19171835|accessdate=2009-06-23 |pmc=2677504}}</ref><ref name="pmid18756085">{{cite journal |author=Sorrentino G, Migliaccio R, Bonavita V |title=Treatment of vascular dementia: the route of prevention |journal=[[European Neurology]] |volume=60 |issue=5 |pages=217–23 |year=2008 |pmid=18756085 |doi=10.1159/000151696 |url=http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000151696|accessdate=2009-06-23}}</ref>

[[Cerebral blood flow]] remains unchanged over a wide range of [[arterial pressures]] (mean arterial pressure of 50–150 mmHg) through a process termed [[autoregulation of blood flow]].<ref name="isbn0-7216-0240-1">{{cite book |author=Hall, John E.; Guyton, Arthur C. |authorlink= |editor= |others= |title=Textbook of medical physiology |edition= |language= |publisher=Elsevier Saunders |location=St. Louis, Mo |year=2006 |origyear= |pages=762 |quote= |isbn=0-7216-0240-1 |oclc= |doi= |url= |accessdate=}}</ref> Signs and symptoms of [[hypertensive encephalopathy]] may include severe [[headache]], [[nausea]] and [[vomiting]] (often of a projectile nature), focal neurologic signs, and alterations in [[mental status]]. Untreated, hypertensive encephalopathy may progress to [[stupor]], [[coma]], [[seizures]], and [[death]] within hours.<ref name="pmid3055687">{{cite journal |author=Müller-Wiefel DE |title=[The hypertensive crisis in childhood] |language=German |journal=[[Wiener Klinische Wochenschrift]] |volume=100 |issue=16 |pages=547–55 |year=1988 |month=August |pmid=3055687 |doi= |url= }}</ref><ref name="pmid7604239">{{cite journal |author=Isles CG |title=Management of hypertensive crises |journal=[[Scottish Medical Journal]] |volume=40 |issue=1 |pages=23–5 |year=1995 |month=February |pmid=7604239 |doi= |url= }}</ref><ref name="pmid19035716">{{cite journal |author=Refai D, Botros JA, Strom RG, Derdeyn CP, Sharma A, Zipfel GJ |title=Spontaneous isolated convexity subarachnoid hemorrhage: presentation, radiological findings, differential diagnosis, and clinical course |journal=[[Journal of Neurosurgery]] |volume=109 |issue=6 |pages=1034–41 |year=2008 |month=December |pmid=19035716 |doi=10.3171/JNS.2008.109.12.1034 |url=http://thejns.org/doi/abs/10.3171/JNS.2008.109.12.1034?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov|accessdate=2009-06-23}}</ref><ref name="pmid18271765">{{cite journal |author=O'Hara McCoy H |title=Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care |journal=[[Journal of the American Academy of Nurse Practitioners]] |volume=20 |issue=2 |pages=100–6 |year=2008 |month=February |pmid=18271765 |doi=10.1111/j.1745-7599.2007.00292.x |url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1041-2972&date=2008&volume=20&issue=2&spage=100|accessdate=2009-06-23}}</ref> It is important to distinguish hypertensive encephalopathy from other neurologic syndromes that may be associated with hypertension, e.g., [[cerebral ischemia]], hemorrhagic or thrombotic stroke, [[Epilepsy|seizure disorder]], mass lesions, [[Idiopathic intracranial hypertension|pseudotumor cerebri]], [[delirium tremens]], [[meningitis]], [[acute intermittent porphyria]], [[Physical trauma|traumatic]] or chemical injury to the brain, and [[uremic encephalopathy]].<ref name="isbn0-07-147691-1"/>

== Complications affecting the eye ==
{{Main|Hypertensive retinopathy}}
[[Image:Hypertensiveretinopathy.jpg|thumb|right|290px|[[Hypertensive retinopathy]] with AV nicking and mild vascular tortuosity]]
[[Hypertensive retinopathy]] is a condition characterized by a spectrum of retinal vascular signs in people with [[elevated blood pressure]].<ref name="pmid7155523">{{cite journal |author=Walsh JB |title=Hypertensive retinopathy. Description, classification, and prognosis |journal=[[Ophthalmology (journal)|Ophthalmology]] |volume=89 |issue=10 |pages=1127–31 |year=1982 |month=October |pmid=7155523 |doi= |url= }}</ref> It was first described by Liebreich in 1859.<ref>Liebreich R. Ophthalmoskopischer Befund bei Morbus Brightii. Albrecht von Graefes Arch Ophthalmol 1859; 5: 265–268.</ref> The [[retinal]] [[circulatory system|circulation]] undergoes a series of pathophysiological changes in response to elevated blood pressure.<ref name="pmid7155524">{{cite journal |author=Tso MO, Jampol LM |title=Pathophysiology of hypertensive retinopathy |journal=[[Ophthalmology (journal)|Ophthalmology]] |volume=89 |issue=10 |pages=1132–45 |year=1982 |month=October |pmid=7155524 |doi= |url= }}</ref> In the initial, [[vasoconstriction|vasoconstrictive stage]], there is [[vasospasm]] and an increase in retinal [[arteriolar tone]] owing to local [[autoregulatory mechanisms]]. This stage is seen clinically as a generalized narrowing of the [[retinal arterioles]]. Persistently elevated blood pressure leads to [[intimal]] thickening, [[hyperplasia]] of the [[media wall]], and [[hyaline]] degeneration in the subsequent, [[Sclerosis (medicine)|sclerotic]], stage. This stage corresponds to more severe generalized and focal areas of arteriolar narrowing, changes in the arteriolar and venular junctions, and alterations in the arteriolar light reflex (i.e., widening and accentuation of the central light reflex, or "copper wiring").<ref name="pmid15564546">{{cite journal |author=Wong TY, Mitchell P |title=Hypertensive retinopathy |journal=[[The New England Journal of Medicine]] |volume=351 |issue=22 |pages=2310–7 |year=2004 |month=November |pmid=15564546 |doi=10.1056/NEJMra032865 |url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=15564546&promo=ONFLNS19|accessdate=2009-06-24}}</ref>

This is followed by an [[exudative]] stage, in which there is disruption of the [[blood–retina barrier]], [[necrosis]] of the [[smooth muscles]] and [[endothelial cells]], exudation of [[blood]] and [[lipids]], and retinal [[ischemia]]. These changes are manifested in the retina as [[microaneurysms]], [[hemorrhages]], hard exudates, and cotton-wool spots. Swelling of the [[optic disk]] may occur at this time and usually indicates severely elevated blood pressure (i.e., [[malignant hypertension]]). Because better methods for the control of blood pressure are now available in the general population, malignant hypertension is rarely seen. In contrast, other retinal vascular complications of hypertension, such as [[macroaneurysms]] and [[branch-vein occlusions]], are not uncommon in patients with chronically elevated blood pressure. These stages of hypertensive retinopathy however, may not be sequential.<ref name="pmid7155524"/><ref name="pmid12037695">{{cite journal |author=Pache M, Kube T, Wolf S, Kutschbach P |title=Do angiographic data support a detailed classification of hypertensive fundus changes? |journal=[[Journal of Human Hypertension]] |volume=16 |issue=6 |pages=405–10 |year=2002 |month=June |pmid=12037695 |doi=10.1038/sj.jhh.1001402}}</ref> For example, signs of retinopathy that reflect the exudative stage, such as [[retinal]] [[hemorrhage]] or [[microaneurysm]], may be seen in eyes that do not have features of the sclerotic stage,<ref name="pmid7155524"/> The exudative signs are nonspecific, since they are seen in [[diabetes]] and other conditions.

== Complications affecting the kidneys ==
{{Main|Hypertensive nephropathy}}
[[Hypertension]] is a [[risk factor]] for renal injury and [[end stage renal disease|ESRD]].<ref name="pmid17451140">{{cite journal |author=Krzesinski JM, Cohen EP |title=Hypertension and the kidney |journal=[[Acta Clinica Belgica]] |volume=62 |issue=1 |pages=5–14 |year=2007 |pmid=17451140 |doi= |url= }}</ref><ref name="pmid18630636">{{cite journal |author=Monhart V |title=[Diabetes mellitus, hypertension and kidney] |language=Czech |journal=[[Vnitr̆ní Lékar̆ství]] |volume=54 |issue=5 |pages=499–504, 507 |year=2008 |month=May |pmid=18630636 |doi= |url= }}</ref><ref name="pmid18677585">{{cite journal |author=Hohenstein K, Watschinger B |title=[Hypertension and the kidney] |language=German |journal=[[Wiener Medizinische Wochenschrift]] |volume=158 |issue=13–14 |pages=359–64 |year=2008 |pmid=18677585 |doi=10.1007/s10354-008-0558-3}}</ref><ref name="pmid19427500">{{cite journal |author=Khosla N, Kalaitzidis R, Bakris GL |title=The kidney, hypertension, and remaining challenges |journal=[[The Medical Clinics of North America]] |volume=93 |issue=3 |pages=697–715, Table of Contents |year=2009 |month=May |pmid=19427500 |doi=10.1016/j.mcna.2009.02.001 |url=http://journals.elsevierhealth.com/retrieve/pii/S0025-7125(09)00016-9|accessdate=2009-06-23}}</ref><ref name="pmid19225145">{{cite journal |author=Ponnuchamy B, Khalil RA |title=Cellular mediators of renal vascular dysfunction in hypertension |journal=[[American Journal of Physiology]] |volume=296 |issue=4 |pages=R1001–18 |year=2009 |month=April |pmid=19225145 |doi=10.1152/ajpregu.90960.2008 |url=http://ajpregu.physiology.org/cgi/pmidlookup?view=long&pmid=19225145|accessdate=2009-06-23 |pmc=2698613}}</ref><ref name="pmid19102111">{{cite journal |author=Niang A |title=[Arterial hypertension and the kidney] |language=French |journal=[[Dakar Médical]] |volume=53 |issue=1 |pages=1–6 |year=2008 |pmid=19102111 |doi= |url= }}</ref><ref name="pmid18775113">{{cite journal |author=Palmer BF |title=Hypertension management in patients with chronic kidney disease |journal=[[Current Hypertension Reports]] |volume=10 |issue=5 |pages=367–73 |year=2008 |month=October |pmid=18775113 |doi= 10.1007/s11906-008-0069-z|url= }}</ref> Renal risk appears to be more closely related to [[Systole (medicine)|systolic]] than to [[diastolic]] [[blood pressure]],<ref name="pmid16336577">{{cite journal |author=Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R |title=Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis |journal=[[Kidney International Supplement]] |volume= 68|issue=99 |pages=S52–6 |year=2005 |month=December |pmid=16336577 |doi=10.1111/j.1523-1755.2005.09910.x |url= }}</ref><ref name="pmid9324121">{{cite journal |author=Schmitz A |title=Microalbuminuria, blood pressure, metabolic control, and renal involvement: longitudinal studies in white non-insulin-dependent diabetic patients |journal=[[American Journal of Hypertension]] |volume=10 |issue=9 Pt 2 |pages=189S–197S |year=1997 |month=September |pmid=9324121 |doi= 10.1016/S0895-7061(97)00152-0|url= }}</ref> and [[black men]] are at greater risk than [[White people|white men]] for developing ESRD at every level of blood pressure.<ref name="pmid17940670">{{cite journal |author=Lindhorst J, Alexander N, Blignaut J, Rayner B |title=Differences in hypertension between blacks and whites: an overview |journal=[[Cardiovascular Journal of Africa]] |volume=18 |issue=4 |pages=241–7 |year=2007 |pmid=17940670 |doi= |url=http://blues.sabinet.co.za/WebZ/Authorize?sessionid=0:autho=pubmed:password=pubmed2004&/AdvancedQuery?&format=F&next=images/ejour/cardio/cardio_v18_n4_a9.pdf|accessdate=2009-06-23}}</ref><ref name="pmid14730541">{{cite journal |author=Swift PA, Macgregor GA |title=Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin |journal=[[Advances in Renal Replacement Therapy]] |volume=11 |issue=1 |pages=76–86 |year=2004 |month=January |pmid=14730541 |doi= 10.1053/j.arrt.2003.10.011|url=http://journals.elsevierhealth.com/retrieve/pii/S1073444903000700|accessdate=2009-06-23}}</ref><ref name="pmid10904013">{{cite journal |author=Ergul A |title=Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension |journal=[[Hypertension (journal)|Hypertension]] |volume=36 |issue=1 |pages=62–7 |year=2000 |month=July |pmid=10904013 |doi= |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=10904013|accessdate=2009-06-23}}</ref><ref name="pmid10760070">{{cite journal |author=Ferrari P, Krozowski Z |title=Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation |journal=[[Kidney International]] |volume=57 |issue=4 |pages=1374–81 |year=2000 |month=April |pmid=10760070 |doi=10.1046/j.1523-1755.2000.00978.x}}</ref><ref name="pmid9395558">{{cite journal |author=Campese VM |title=The kidney in the hypertensive black |journal=[[Ethnicity & Health]] |volume=1 |issue=2 |pages=145–51 |year=1996 |month=May |pmid=9395558 |doi= 10.1080/13557858.1996.9961781|url= }}</ref>

The [[atherosclerosis|atherosclerotic]], hypertension-related vascular lesions in the kidney primarily affect the preglomerular arterioles,<ref name="pmid16336577"/><ref name="pmid11753090">{{cite journal |author=Bidani AK, Griffin KA |title=Long-term renal consequences of hypertension for normal and diseased kidneys |journal=[[Current Opinion in Nephrology and Hypertension]] |volume=11 |issue=1 |pages=73–80 |year=2002 |month=January |pmid=11753090 |doi= 10.1097/00041552-200201000-00011|url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1062-4821&volume=11&issue=1&spage=73|accessdate=2009-06-23}}</ref><ref name="pmid15797666">{{cite journal |author=Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J |title=A unifying pathway for essential hypertension |journal=[[American Journal of Hypertension]] |volume=18 |issue=3 |pages=431–40 |year=2005 |month=March |pmid=15797666 |doi=10.1016/j.amjhyper.2004.08.035}}</ref> resulting in ischemic changes in the glomeruli and postglomerular structures.<ref name="isbn0-07-147691-1"/> [[Glomerular]] injury may also be a consequence of direct damage to the glomerular [[capillaries]] due to glomerular hyperperfusion. Glomerular pathology progresses to [[glomerulosclerosis]],<ref name="pmid18039119">{{cite journal |author=Kwoh C, Shannon MB, Miner JH, Shaw A |title=Pathogenesis of nonimmune glomerulopathies |journal=[[Annual Review of Pathology]] |volume=1 |issue= |pages=349–74 |year=2006 |pmid=18039119 |doi=10.1146/annurev.pathol.1.110304.100119 |url=http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pathol.1.110304.100119?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov|accessdate=2009-06-23}}</ref><ref name="pmid18333378">{{cite journal |author=Stoian M, Radulian G, Chiţac D, Simion E, Stoica V |title=A clinical approach in regression of glomerulosclerosis |journal=[[Romanian Journal of Internal Medicine]] |volume=45 |issue=2 |pages=215–8 |year=2007 |pmid=18333378 |doi= |url= }}</ref> and eventually the [[renal tubules]] may also become [[ischemic]] and gradually [[atrophic]]. The renal lesion associated with [[malignant hypertension]] consists of [[fibrinoid necrosis]] of the [[afferent arterioles]],<ref name="pmid9356598">{{cite journal |author=Ono H, Ono Y |title=Nephrosclerosis and hypertension |journal=[[The Medical Clinics of North America]] |volume=81 |issue=6 |pages=1273–88 |year=1997 |month=November |pmid=9356598 |doi= 10.1016/S0025-7125(05)70582-4|url= }}</ref><ref name="pmid2620472">{{cite journal |author=Muirhead EE, Pitcock JA |title=Histopathology of severe renal vascular damage in blacks |journal=[[Clinical Cardiology]] |volume=12 |issue=12 Suppl 4 |pages=IV58–65 |year=1989 |month=December |pmid=2620472 |doi= |url= }}</ref><ref name="pmid3687809">{{cite journal |author=Dustan HP, Curtis JJ, Luke RG, Rostand SG |title=Systemic hypertension and the kidney in black patients |journal=[[The American Journal of Cardiology]] |volume=60 |issue=17 |pages=73I–77I |year=1987 |month=December |pmid=3687809 |doi= 10.1016/0002-9149(87)90464-4|url= }}</ref><ref name="pmid3306206">{{cite journal |author=Schwartz GL, Strong CG |title=Renal parenchymal involvement in essential hypertension |journal=[[The Medical Clinics of North America]] |volume=71 |issue=5 |pages=843–58 |year=1987 |month=September |pmid=3306206 |doi= |url= }}</ref><ref name="pmid3764316">{{cite journal |author=Cimprich RE, Ziemba LJ, Kutz SA, Robertson JL, Cockrell B |title=Experimentally induced malignant hypertension in beagle dogs |journal=[[Toxicologic Pathology]] |volume=14 |issue=2 |pages=183–7 |year=1986 |pmid=3764316 |doi= 10.1177/019262338601400206|url= }}</ref><ref name="pmid7461792">{{cite journal |author=Queiroz FP, Rojo-Ortega JM, Genest J |title=Metaischemic (post-Goldblatt) hypertensive vascular disease in rats |journal=[[Hypertension (journal)|Hypertension]]  |volume=2 |issue=6 |pages=765–70 |year=1980 |pmid=7461792 |doi= |url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=7461792|accessdate=2009-06-24}}</ref><ref name="pmid463685">{{cite journal |author=Weller RO |title=Vascular pathology in hypertension |journal=[[Age and Ageing]] |volume=8 |issue=2 |pages=99–103 |year=1979 |month=May |pmid=463685 |doi= |url=http://ageing.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=463685|accessdate=2009-06-24}}</ref> sometimes extending into the [[glomerulus]], and may result in focal [[necrosis]] of the [[glomerular tuft]].<ref name="pmid3687809"/><ref name="pmid987010">{{cite journal |author=Sinclair RA, Antonovych TT, Mostofi FK |title=Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic study |journal=[[Human Pathology]] |volume=7 |issue=5 |pages=565–88 |year=1976 |month=September |pmid=987010 |doi= 10.1016/S0046-8177(76)80103-7|url= }}</ref><ref name="pmid9853269">{{cite journal |author=Linz W, Becker RH, Schölkens BA, Wiemer G, Keil M, Langer KH |title=Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats |journal=[[Kidney International]] |volume=54 |issue=6 |pages=2037–44 |year=1998 |month=December |pmid=9853269 |doi=10.1046/j.1523-1755.1998.00208.x}}</ref>

Clinically, [[macroalbuminuria]] (a random [[urine]] [[albumin]]/[[creatinine]] ratio > 300&nbsp;mg/g) or [[microalbuminuria]] (a random urine [[albumin]]/[[creatinine]] ratio 30–300&nbsp;mg/g) are early markers of renal injury. These are also [[risk factors]] for renal disease progression and for [[cardiovascular disease]].<ref name="isbn0-07-147691-1"/>

==Complications associated to diabetes and hypertension==
Diabetes has several complications of which one is hypertension or high blood pressure. Data indicate that at least 60-80 percent of individuals whom develop diabetes will eventually develop high blood pressure. The high blood pressure is gradual at early stages and may take at least 10–15 years to fully develop. Besides diabetes, other factors that may also increase high blood pressure include [[obesity]], [[insulin]] resistance and [[Hypercholesterolemia|high cholesterol]] levels. In general, fewer than 25 percent of diabetics have good control of their blood pressure. The presence of high blood pressure in diabetes is associated with a 4 fold increase in death chiefly from heart disease and strokes.<ref>[http://www.mja.com.au/public/issues/misc/gilbert/gilbert.html Diabetes and Hypertension] Medical Journal of Australia. 2010-02-09</ref>

'''The chief reason why people with diabetes develop high blood pressure is hardening of the [[artery|arteries]].''' '''Diabetes tends to speed up the process of atherosclerosis. The other fact about diabetes is that it affects both large and small [[blood vessel]]s in the body. Over time, blood vessels become clogged with [[Adipose tissue|fatty depots]], become non-compliant and lose their elasticity. The process of atherosclerosis is a lot faster in diabetic individuals whom do not have good control of their [[blood sugar]]s.''' The high blood pressure eventually leads to heart failure, strokes, heart attacks, [[blindness]], [[renal failure|kidney failure]], loss of [[libido]] and poor circulation of blood in the legs. When the [[Circulatory system|blood supply]] to the feet is compromised, the chances of infections and [[amputation]]s also increases.
All diabetics should know that even mild elevations in blood pressure can be detrimental to health. '''Studies have shown that diabetics with even a slight elevation in blood pressure have 2-3 times the risk of heart disease compared to individuals without diabetes.'''<ref>[http://diabetes.about.com/lw/Health-Medicine/Conditions-and-diseases/Diabetes-and-Hypertension.htm Diabetes associated to Hypertension] About health portal. 2010-02-09</ref>

'''Blood pressure readings do vary but experts recommend that blood pressure should not range above 130/80. Secondly, high blood pressure is a silent disease and thus it is vital for all diabetics to regularly check their blood pressure or have it checked at a doctor's office on a regular basis. The [[American Diabetes Association]] recommends that all diabetics get their blood pressure measured by a health care professional at least 2-5 times a year.'''<ref>Medical journal of Australia. [http://www.mja.com.au/public/issues/misc/gilbert/gilbert.html "Hypertension and Diabetes overview"] 2010-02-09.</ref>

===Treatment for diabetic patients with hypertension===
Once blood pressure is found to be high in diabetics, there are ways to treat it:

Medications  like the [[Angiotensin-converting enzyme]] inhibitors (ACEI) are widely used to control blood pressure in diabetics. These medications not only control blood pressure but also delay or prevent the development of kidney disease in diabetes. Many studies have shown that ACEI should be the drugs of first choice in diabetics with high blood pressure. Other medications used to treat high blood pressure include water pills. Sometimes, a combination of medications is used to treat high blood pressure. All diabetics should quit [[smoking]]. The combination of diabetes and smoking  usually leads to amputations of the toes and feet.
Measure your blood sugars regularly, and make sure that they are well balanced as the majority of complications of diabetes can be prevented by ensuring such blood sugars stay within normal limits.<ref>[http://www.diabeteshypertension.net/ Diabetes Hypertension Guidelines: Treatment And Symptoms] 2010-02-09</ref>
It is also recommended to eat a healthy diet and avoid sugary foods and limit the intake of salt. Also, ensure that your [[cholesterol]] levels are under control. Exercise is a must for all diabetics. Walking twice a day for 30 minutes can be a fair substitute for those not engaged in intense gym activities. Losing weight is also beneficial as this has been shown to improve blood sugar control, increase insulin sensitivity and reduce blood pressure.<ref>American Academy of Family Physicians. [http://www.aafp.org/afp/2002/1001/p1209.html "Controlling Hypertension in Patients with Diabetes"] 2010-02-09.</ref>

== References ==
{{reflist|2}}

{{Vascular diseases}}

[[Category:Hypertension]]
[[Category:Cardiovascular diseases]]